How well can electronic health records from primary care identify Alzheimer’s disease cases?
dc.contributor.author
dc.date.accessioned
2020-06-15T11:18:02Z
dc.date.available
2020-06-15T11:18:02Z
dc.date.issued
2019-07-05
dc.identifier.issn
1179-1349
dc.identifier.uri
dc.description.abstract
Background: Electronic health records (EHR) from primary care are emerging in
Alzheimer’s disease (AD) research, but their accuracy is a concern. We aimed to
validate AD diagnoses from primary care using additional information provided by general
practitioners (GPs), and a register of dementias.
Patients and methods: This retrospective observational study obtained data from the
System for the Development of Research in Primary Care (SIDIAP). Three algorithms
combined International Statistical Classification of Diseases (ICD-10) and Anatomical
Therapeutic Chemical codes to identify AD cases in SIDIAP. GPs evaluated dementia
diagnoses by means of an online survey. We linked data from the Register of Dementias
of Girona and from SIDIAP. We estimated the positive predictive value (PPV) and sensitivity
and provided results stratified by age, sex and severity.
Results: Using survey data from the GPs, PPV of AD diagnosis was 89.8% (95% CI:
84.7–94.9). Using the dataset linkage, PPV was 74.8 (95% CI: 73.1–76.4) for algorithm A1
(AD diagnoses), and 72.3 (95% CI: 70.7–73.9) for algorithm A3 (diagnosed or treated
patients without previous conditions); sensitivity was 71.4 (95% CI: 69.6–73.0) and 83.3
(95% CI: 81.8–84.6) for algorithms A1 (AD diagnoses) and A3, respectively. Stratified
results did not differ by age, but PPV and sensitivity estimates decreased amongst men and
severe patients, respectively.
Conclusions: PPV estimates differed depending on the gold standard. The development of
algorithms integrating diagnoses and treatment of dementia improved the AD case ascertainment. PPV and sensitivity estimates were high and indicated that AD codes recorded in
a large primary care database were sufficiently accurate for research purposes
dc.description.sponsorship
This
work was supported by the Real world Outcomes across
the AD spectrum for better care: Multi-modal data Access
Platform (ROADMAP) from the Innovative Medicines
Initiative (Grant Agreement number 116020). This project
was also supported by clinical research grants from Carlos
III Health Institute, within the Net for Research in Preventive
Activities and Health Enhancement (RedIAPP RD16/0007/
0004) framework, and from the Agency for Management of
University and Research Grants (2017 SGR 1146)
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Dove Medical Press
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.2147/CLEP.S206770
dc.relation.ispartof
Clinical Epidemiology, 2019, vol. 11, p. 509-518
dc.relation.ispartofseries
Articles publicats (D-CM)
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights.uri
dc.subject
dc.title
How well can electronic health records from primary care identify Alzheimer’s disease cases?
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
030036
dc.type.peerreviewed
peer-reviewed